- $9.69bn
- $14.57bn
- $13.18bn
Henry Schein falls after longtime CEO to retire
Brief: Henry Schein Amends And Restates $750 Million Credit Agreement - SEC Filing
Brief: Henry Schein Announces Completion Of Strategic Investment By Kkr And Appointment Of Dan Daniel To Board Of Directors
Henry Schein falls on Q1 revenue miss
Henry Schein Inc reports results for the quarter ended March 31 - Earnings Summary
Henry Schein misses quarterly revenue estimates on weak demand for dental products
U.S. STOCKS ON THE MOVE-US drugmakers, regional banks, chip stocks
Dental and medical supply firms fall after Trump's reciprocal tariff announcement
U.S. RESEARCH ROUNDUP- Advanced Micro Devices, Carmax, Lockheed Martin
Brief: KKR & Co reports 9.7% stake in Henry Schein as of March 10 - SEC Filing
Brief: Henry Schein Acquires R. Weinstein
U.S. STOCKS ON THE MOVE-Maze Therapeutics, UFP Technologies, Itron
U.S. STOCKS ON THE MOVE-AxoGen, Portillo, Cisco Systems
Henry Schein forecasts 2025 profit below estimates on weak demand for dental products (updated)
Henry Schein falls on weak 2025 profit forecast
Henry Schein Inc reports results for the quarter ended December 31 - Earnings Summary
Henry Schein forecasts 2025 profit below estimates on weak demand for dental products
U.S. STOCKS ON THE MOVE-Signing Day Sports, Merchants Bancorp, Stride
U.S. STOCKS ON THE MOVE-89Bio, Brinker, Apple